Literature DB >> 20411295

Interferon-gamma releasing assay versus tuberculin skin testing for latent tuberculosis infection in targeted screening programs for high risk immigrants.

G Orlando1, S Merli, L Cordier, F Mazza, G Casazza, A M Villa, L Codecasa, E Negri, A Cargnel, M Ferrarese, G Rizzardini.   

Abstract

BACKGROUND: Recent immigrants from developing countries (<2 years since immigration) are at very high risk of active TB disease due to reactivation of latent infections acquired in the country of origin. In industrialized low-incidence TB countries targeted testing programs for high risk groups could allow the detection of latently infected persons who would likely benefit from a course of preventive treatment. In this study we evaluated the tuberculin skin test (TST) and interferon-gamma enzyme-linked immunosorbent assay (QuantiFERON TB-gold in tube, QFT-IT) strategies for TB infection screening programs in recent immigrants from highly endemic countries. PATIENTS AND METHODS: This is a prospective cross-sectional study. Paired tests performed in 1,130 immigrants attending an outpatient ward, between 2005 and 2007 for any health problem were evaluated by intention-to-treat (ITT) and per-protocol (PP) analysis for efficiency and efficacy of screening program.
RESULTS: Positive TST and QFT-IT were observed in 36.04 versus 29.82% (ITT) and in 45.27 versus 30.22% (PP) respectively. A higher drop-out rate was observed for TST (20.35 vs. 1.33%) (p < 0.0001). Second level assessment was accepted by half of the TST positive patients. Overall agreement rate between 887 paired tests was fair (k = 0.38). Higher k values were observed for higher TB prevalence rate in the country of origin (k = 0.43), for TST induration diameters >20 mM (k = 0.47), in subjects aged 40-50 years (k = 0.41) and in unvaccinated persons (k = 0.40). In a multiple logistic regression model continent of origin, class of TB prevalence in the country of origin and contacts with TB patients were found to be significantly associated with the probability of TST and QFT-IT positive result. Low education levels were associated only to an increased risk of TST positive results.
CONCLUSIONS: The drawback of the TST screening strategy in recent immigrants from highly endemic countries is due to low sensitivity/specificity of the test and to high drop-out rate with an overall significant lowering in strategy efficacy/efficiency. The higher QFT-IT specificity prevents unnecessary overload of the health care system and, although more expensive, might represent a cost-effective alternative to TST in targeted screening programs directed to high risk populations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20411295     DOI: 10.1007/s15010-010-0015-2

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  36 in total

1.  Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis.

Authors:  Pernille Ravn; Martin E Munk; Ase B Andersen; Bettina Lundgren; Jens D Lundgren; Lars N Nielsen; Axel Kok-Jensen; Peter Andersen; Karin Weldingh
Journal:  Clin Diagn Lab Immunol       Date:  2005-04

2.  Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy.

Authors:  C S Hirsch; Z Toossi; C Othieno; J L Johnson; S K Schwander; S Robertson; R S Wallis; K Edmonds; A Okwera; R Mugerwa; P Peters; J J Ellner
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

3.  Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2000-06-09

4.  Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-gamma release assays.

Authors:  Gerald H Mazurek; Margan J Zajdowicz; Arlene L Hankinson; Daniel J Costigan; Sean R Toney; James S Rothel; Laura J Daniels; F Brian Pascual; Nong Shang; Lisa W Keep; Philip A LoBue
Journal:  Clin Infect Dis       Date:  2007-08-24       Impact factor: 9.079

5.  Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis.

Authors:  Gerald H Mazurek; Stephen E Weis; Patrick K Moonan; Charles L Daley; John Bernardo; Alfred A Lardizabal; Randall R Reves; Sean R Toney; Laura J Daniels; Philip A LoBue
Journal:  Clin Infect Dis       Date:  2007-08-24       Impact factor: 9.079

6.  LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement.

Authors:  U Mack; G B Migliori; M Sester; H L Rieder; S Ehlers; D Goletti; A Bossink; K Magdorf; C Hölscher; B Kampmann; S M Arend; A Detjen; G Bothamley; J P Zellweger; H Milburn; R Diel; P Ravn; F Cobelens; P J Cardona; B Kan; I Solovic; R Duarte; D M Cirillo
Journal:  Eur Respir J       Date:  2009-05       Impact factor: 16.671

7.  Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis.

Authors:  A K Detjen; T Keil; S Roll; B Hauer; H Mauch; U Wahn; K Magdorf
Journal:  Clin Infect Dis       Date:  2007-06-15       Impact factor: 9.079

Review 8.  Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy.

Authors:  Ajit Lalvani
Journal:  Chest       Date:  2007-06       Impact factor: 9.410

9.  Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.

Authors:  Dario Ponce de Leon; Eduardo Acevedo-Vasquez; Sergio Alvizuri; Cesar Gutierrez; Mariano Cucho; Jose Alfaro; Risto Perich; Alfredo Sanchez-Torres; Cesar Pastor; Cesar Sanchez-Schwartz; Mariela Medina; Rocio Gamboa; Manuel Ugarte
Journal:  J Rheumatol       Date:  2008-04-01       Impact factor: 4.666

10.  Feasibility of commercial interferon-gamma-based methods for the diagnosis of latent Mycobacterium tuberculosis infection in Finland, a country of low incidence and high bacille Calmette-Guérin vaccination coverage.

Authors:  T Tuuminen; S Sorva; K Liippo; T Vasankari; H Soini; B Eriksén-Neuman; A Miettinen; I J Seppälä
Journal:  Clin Microbiol Infect       Date:  2007-05-14       Impact factor: 8.067

View more
  8 in total

Review 1.  A systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants.

Authors:  Jonathon R Campbell; Jane Krot; Kevin Elwood; Victoria Cook; Fawziah Marra
Journal:  Mol Diagn Ther       Date:  2015-02       Impact factor: 4.074

2.  Quality improvement of tuberculosis screening in foreign-born patients.

Authors:  Jordan A Kempker; Francisco J Pasquel; Maria S Castejon; Anna Acosta; Elisa Zaragoza-Macias; Nurcan Ilksoy; Stacy Higgins; Ildefonso Tellez
Journal:  J Immigr Minor Health       Date:  2012-02

3.  Implementation of an interferon-gamma release assay to screen for tuberculosis in refugees and immigrants.

Authors:  Terri Simpson; Julie Tomaro; Cynthia Jobb
Journal:  J Immigr Minor Health       Date:  2013-08

4.  Community-based evaluation of immigrant tuberculosis screening using interferon γ release assays and tuberculin skin testing: observational study and economic analysis.

Authors:  Manish Pareek; Marion Bond; Jennifer Shorey; Suranjith Seneviratne; Margaret Guy; Peter White; Ajit Lalvani; Onn Min Kon
Journal:  Thorax       Date:  2012-06-12       Impact factor: 9.139

5.  Tuberculosis infection among homeless persons and caregivers in a high-tuberculosis-prevalence area in Japan: a cross-sectional study.

Authors:  Takahiro Tabuchi; Toshio Takatorige; Yukio Hirayama; Nobuaki Nakata; Shigeyoshi Harihara; Akira Shimouchi; Koshiro Fujita; Hiroko Yoshida; Yoshitaka Tamura; Takayuki Nagai; Tomoshige Matsumoto; Tetsuya Takashima; Hiroyasu Iso
Journal:  BMC Infect Dis       Date:  2011-01-21       Impact factor: 3.090

6.  Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis.

Authors:  Manish Pareek; John P Watson; L Peter Ormerod; Onn Min Kon; Gerrit Woltmann; Peter J White; Ibrahim Abubakar; Ajit Lalvani
Journal:  Lancet Infect Dis       Date:  2011-04-20       Impact factor: 25.071

7.  Determining the Latent Tuberculosis Infection by IFN - γ Elispot Assay in Healthcare Workers From University Hospitals of Shiraz, South West of Iran.

Authors:  Mohammad Taheri; Hamid Bazrafkan; Mojtaba Habibagahi
Journal:  Iran Red Crescent Med J       Date:  2013-06-05       Impact factor: 0.611

Review 8.  The impact of migration on tuberculosis epidemiology and control in high-income countries: a review.

Authors:  Manish Pareek; Christina Greenaway; Teymur Noori; Jose Munoz; Dominik Zenner
Journal:  BMC Med       Date:  2016-03-23       Impact factor: 8.775

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.